Mitochondrial Disorders Clinical Trial
Official title:
DINAMITE Study: An Explorative Study of the Effect of Dietary Intervention on Body Function and Quality of Life in Adults With Mitochondrial Disease Caused by the m.3243A>G Mutation.
The m.3243A>G mutation is the most frequent cause of mitochondrial disease in adults, for
which currently no therapy is available and treatment is solely supportive. Since both
malnutrition and obesity are frequently seen in these patients, an adequate nutritional
intervention to improve body composition and function might improve the quality of life of
these patients.
Hypothesis / research questions Hypothesis part 1: Patients with mitochondrial disorders
caused by the m.3243 A>G mutation have an increased risk for malnutrition.
Hypothesis part 2 : Intervention study: Dietary intervention in adults with a mitochondrial
disorder caused by the m.3243 A>G mutation has a positive effect on nutritional status,
activity, hand grip strength, body composition, food intake, fatigue and quality of life.
Background
The Nijmegen Centre for Metabolic Disease (NCMD) harbors a unique research center with much
experience in the characterization of the group of patients with the m3243A>G mutation.
For a mitochondrial disease no therapy is available. Treatment is supportive, and aims at
improving the quality of life. Clinical findings in patients with mitochondrial diseases may
both comprise malnutrition and obesity. While a nutritional intervention might constitute a
symptomatic treatment for these patients, there are very few data in adults to guide such a
strategy.
Malnutrition is defined as a state of nutrition in which a deficiency, excess (or imbalance)
of energy, protein, and other nutrients causes measurable adverse effects on body
composition and function, and clinical outcome. In patients with mitochondrial disease there
is by definition malnutrition on a cellular level due to disturbed metabolism with energy
deficit. A logical next step is to study the effect of this energy shortage on complaints in
the adult population by describing characteristics of this patient group in relation to the
nutritional status. In the same vein, a controlled dietary intervention might result in an
evidence based dietary therapy.
Frequent symptoms of patients with OXPHOS disorders include e gastrointestinal problems,
fatigue and dysphagia. We suspect that these symptoms increase the risk for malnutrition.
Research in patients with neuromuscular disorders have demonstrated that none of the
patients had an adequate nutritional state, with a a lowered Fat Free Mass and a high fat
percentage.
Study design:
Part 1 comprises a comprehensive Nutritional Assessment (NA) including indirect calorimetry
(IC), bioimpedance analysis (BIA), anthropometry, eating report, activity measurement using
the actometer, and completion of questionnaires including the Cis-fatigue and SF-36 for
Quality of life.
In Part 2 a 2-armed randomized controlled intervention study is performed . One group starts
with a dietary intervention whereas the second group (controls) starts with a
non-interventional period of 6 months. After this period the dietary intervention is also
performed in the second group . The dietary intervention implies optimizing the diet based
on individually calculated energy and protein requirements, while for remaining nutrients
advise in line with recommended daily amounts (RDA) will be provided. Extended Nutritional
Assessment measurements will be repeated every 3 months. Indirect Calorimetry will be
performed at the start of the study.
Objective of the study:
1. To increase our knowledge about the nutritional status of adult patients with
mitochondrial disease and its determinants.
2. Evaluate effects of a dietary intervention in these patients on nutritional status and
body functions (muscle strength, activity, fatigue) and quality of life.
3. To develop criteria to refer patients with mitochondrial disease for dietary
intervention.
DINAMITE study acronym DIner: Hot meal, super NA: Nutritional Assessment or Nutrition +
Adults MIT MITochondrial disorder E Energy
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06080581 -
Mitochondrial Dysfunctions Driving Insulin Resistance
|
||
Completed |
NCT01137240 -
Gastrointestinal Dysfunction in Children Affected With Mitochondrial Disorders
|
N/A | |
Recruiting |
NCT06213103 -
Mitochondrial Disease-associated ImmunoDeficiencies
|
||
Completed |
NCT00406445 -
Role of p53 Gene in Metabolism Regulation in Patients With Li-Fraumeni Syndrome
|
||
Enrolling by invitation |
NCT01803906 -
Tissue Sample Study for Mitochondrial Disorders
|
||
Recruiting |
NCT01780168 -
The NIH MINI Study: Metabolism, Infection, and Immunity in Inborn Errors of Metabolism
|
||
Recruiting |
NCT01694940 -
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
|
||
Recruiting |
NCT06080594 -
Exercise-mediated Rescue of Mitochondrial Dysfunctions Driving Insulin Resistance
|
N/A | |
Completed |
NCT02804828 -
Mitochondrial Cocktail for Gulf War Illness
|
N/A |